ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is a Biotechnology company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ANIP’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that ANI Pharmaceuticals could be a solid choice for investors.
Current Quarter Estimates for ANIP
In the past 30 days, 1 estimate has gone higher for ANI Pharmaceuticals while none has gone lower in the same time period. The trend has been pretty favorable too, with estimates rising from 36 cents per share 30 days ago, to 80 cents today, a significant move.
Current Year Estimates for ANIP
Meanwhile, ANI Pharmaceuticals current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, with estimates rising from $1.45 per share 30 days ago, to $3.40 today, a significant move.
Bottom Line
The stock has also started to move higher lately, adding 14.6% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future.
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
Original post